Announced

Completed

Bristol Myers Squibb and Bain Capital formed a joint venture.

Synopsis

Bristol Myers Squibb, a biopharmaceutical company, and Bain Capital, a private investment firm, formed a joint venture. Financial terms were not disclosed. “These assets have significant potential, and we are confident that this new company will drive their development to ensure greater impact for patients. Bain Capital’s exceptional track record in building successful life science companies by providing focused development and dedicated resources makes them ideally suited to advance these assets to realize their full promise,” Julie Rozenblyum, BMS Senior Vice President.

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

All rights reserved. Copyright © 2025 Datasite